Send to a Friend Font Size: Increase Decrease

Broadfin Capital

Broadfin Capital's Portfolio

Ticker	# of Shares	Price	Value
	5,574,366	$195.32	$1,088,785,168
	2,707,851	$195.32	$528,897,458
	2,000,000	$195.32	$390,640,000
	1,839,372	$195.32	$359,266,140
SPY	440,000	$737.76	$324,614,400
	1,236,368	$195.32	$241,487,398
IWM	800,000	$290.41	$232,328,000
	1,029,012	$195.32	$200,986,624
	1,003,099	$195.32	$195,925,297
	721,073	$195.32	$140,839,979
View Additional Portfolio Information »

Broadfin Capital

Login to help us fill in information about this entity.

Aegerion Pharma (AEGR), QLT, Inc. (QLTI) Announce Completion of Merger; Name Changes to 'Novelion Therapeutics' Nov 29, 2016 12:11PM

Aegerion Pharmaceuticals, Inc. and QLT Inc. Complete Merger Transaction; QLT to Change Name to Novelion Therapeutics Inc. Nov 29, 2016 12:10PM

Aegerion Pharmaceuticals and QLT Inc. Agree to Strategic Merger Jun 15, 2016 07:00AM

QLT, Deerfield and Other Leading Healthcare Investors Confirm Their Planned Investment in Aralez Pharmaceuticals, a Canadian Domiciled Entity Dec 7, 2015 04:53PM

QLT, Deerfield and Other Leading Healthcare Investors Confirm Their Planned Investment in Aralez Pharmaceuticals, a Canadian Domiciled Entity Dec 7, 2015 04:53PM

Jun 8, 2015 10:49AM QLT Announces Multiple Transactions Designed to Transform the Company and Create Significant Near- and Long-Term Value for Shareholders